Close Menu

CPRIT

With the funding, UTHealth's Wenjin Zheng will form the Data Science and Informatics Core for Cancer Research.

The company aims to enroll 3,000 women in the registry, which it plans to use for research and development of tests to detect and manage pelvic masses.

The new research grants from the Cancer Prevention and Research Institute of Texas include several awards for omics-related projects.

The award will enable Rules-Based Medicine to add to its OncologyMAP panel immunoassays for 150 to 180 blood-based protein biomarkers associated with cancer.

The money is expected to help Mirna meet its goal of filing two INDs by the end of 2011 as it adds staffers to support its drug-development efforts and seeks industry partnerships, according to a company official.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.